Advertisement
News
Advertisement

Boston Scientific gets FDA OK for ION stent system

Mon, 04/25/2011 - 9:39am
Mass High Tech: The Journal of New England Technology

Continuing a spring fling of stent approvals, Boston Scientific Corp. today announced that it had won approval from the FDA for its ION drug-eluting coronary stent.

The U.S. Food and Drug Administration has given the OK for Boston Scientific (NYSE: BSX) to sell the ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System that is made using a “unique platinum chromium alloy.” The ION was approved in May 2010 in Europe and other CE Mark countries, where it is known as the TAXUS Element system.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading